Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AbobotulinumtoxinA for Chronic Exertional Compartment Syndrome
NCT05466539Phase 4Completed
- Sponsor
- Emory University
- Start
- Apr 2024
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Chronic Exertional Compartment Syndrome (CECS), sponsored by Emory University. Started Apr 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Chronic Exertional Compartment Syndrome (CECS)
Beyond the preview
Go deeper on NCT05466539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466539.